Alkermes plc (ALKS) reported earnings from continuing operations of 13 cents per share for first-quarter 2025, which missed the Zacks Consensus Estimate of 28 cents. The company had reported earnings of 21 cents per share in the year-ago quarter.Alkermes’ total revenues of $306.5 million in the first quarter decreased 12.5% from the year-ago quarter’s level due to lower manufacturing and royalty revenues. The top line also missed the Zacks Consensus Estimate of $317 million. (Find the latest EPS estimates a ...

Alkermes (ALKS) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Speaker0 and welcome to Alchemy's First Quarter twenty twenty five Financial Results Conference Call. My name is Maria, and I'll be the operator for today's call. All participant lines will be placed on mute to prevent background Please note that this conference is being recorded. I will now turn the call over to Sandra Khoemps, Senior Vice President of Investor Relations and Corporate Affairs. Sandy, you may now begin. Good morning. Welcome to ...

Alkermes (ALKS) Q1 2025 Earnings Call May 01, 2025 08:00 AM ET Company Participants Sandy Coombs - Senior Vice President, Corporate Affairs and Investor RelationsRichard Pops - Chairman & CEOTodd Nichols - SVP & CCOBlair Jackson - Executive VP & COOCraig Hopkinson - Executive VP of Research & Development and Chief Medical OfficerJames Condulis - Associate Vice President - Biotechnology Equity ResearchUmer Raffat - Senior Managing DirectorAmy Li - SVP Equity ResearchMarc Goodman - Senior MD - NeuroscienceJas ...

—    First Quarter Revenues of $306.5 Million ——    GAAP Net Income of $22.5 Million and Diluted GAAP Earnings per Share of $0.13 ——    Company Reiterates 2025 Financial Expectations —DUBLIN, May 1, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2025."Our first quarter financial performance provides a solid foundation to deliver on our financial guidance for the year. We are in a strong position in this dynamic macroeconomic environment and remain ...